Evidence map›Paper›PMID 42536628›Full record

ArticlePloS one2026

Barriers and levers to using an app for motor function assessment by therapists in hospitals: A qualitative study of the MFM-Play app.

Dominique Vincent-Genod, Manon Verroul, Pascal Rippert, Shotaro Tachibana, Carole Vuillerot, MFM-Play Study Group

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dominique Vincent-GenodHospices Civils de Lyon, Centre Référent Maladies Rares Neuromusculaires- Hôpital Femme Mère Enfant, Lyon, France.ORCID https://orcid.org/0000-0001-8564-7644
Manon VerroulHospices Civils de Lyon, Pôle Santé Publique, Service de Recherche et épidémiologie cliniques, Lyon, France.
Pascal RippertHospices Civils de Lyon, Pôle Santé Publique, Service de Recherche et épidémiologie cliniques, Lyon, France.ORCID https://orcid.org/0000-0003-0185-0659
Shotaro TachibanaHospices Civils de Lyon, Centre Référent Maladies Rares Neuromusculaires- Hôpital Femme Mère Enfant, Lyon, France.
Carole VuillerotHospices Civils de Lyon, Centre Référent Maladies Rares Neuromusculaires- Hôpital Femme Mère Enfant, Lyon, France.
MFM-Play Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Motor Function Measure (MFM) is an important evaluation tool used to monitor the progression of most neuromuscular diseases. However, the MFM is subject to inter-rater variability, and patients must produce their best effort, which can be difficult for children. In response to these issues, we developed a digital app named MFM-Play, designed to optimise completion of the MFM in a fun manner. The objective of this study was to explore barriers and levers to the MFM-Play's use by therapists.

methodWe conducted a qualitative study with rehabilitation professionals who had tested the app in a previous reliability study. Individual interviews based on the Technology Acceptance Model were followed by a focus group based on the interview results. Thematic analysis was performed on transcripts.

resultsSeven therapists participated in the interviews and seven others in the focus group. The results revealed the multi-dimensional features related to adopting the MFM-Play app. Barriers related to ease of use, training and organisational constraints were identified, and were partly due to the additional mental burden of learning to use the technology. However, therapists who were at ease with the digital tool found it useful for their practice. The app also modified patient-therapist dynamics, fostering greater patient autonomy, but sometimes disrupted therapists' habits, by calling into question assessment methods.

conclusionThe MFM-Play app offers considerable practical and efficiency benefits; however, its successful adoption depends on overcoming technical, organisational, and user-specific barriers. This involves providing support for the change in the therapist's stance within the triadic patient-therapist-tablet relationship.

Indexed as

Mobile ApplicationsNeuromuscular DiseasesPhysical TherapistsAdultFemaleFocus GroupsHospitalsHumansMaleQualitative Research

Identifiers

PMID42536628
PMCPMC13426978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.